Remedor Biomed
Remedor Biomed is a clinical research stage biopharmaceutical company focused on revolutionizing complex wound treatment through patented technology. The company aims to provide innovative solutions for diabetic foot ulcers and complex skin wound conditions, significantly impacting patients' lives and healthcare systems.
Remedor Biomed
Patents
Topical erythropoietin formulations and methods for improving wound healing with and cosmetic use of the formulations
2022-01-04 • US-11213569-B2
View DetailsErythropoietin and fibronectin compositions for therapeutic and cosmetic applications
2020-10-06 • US-10792338-B2
View DetailsWhat We Do
WOUNDAGEL™ is Remedor's lead product, designed to accelerate the healing of diabetic foot ulcers. It is formulated to act as a first-line treatment following effective ulcer care, showing faster healing and a greater incidence of ulcer closure in clinical settings.